Prespecified Subgroup Analyses in WJOG4407G Trial, a Randomized Phase III Trial of MFOLFOX6 Plus Bevacizumab Versus Folfiri Plus Bevacizumab in First-Line Treatment for Metastatic Colorectal Cancer

Authors :: Hyodo Ichinosuke
Kawakami Kentaro
Hirashima Tomonori
Okabe Michio
Tamura Fumio
Shinozaki Eiji
Boku Narikazu
Suzuki Kazuya
Tamagawa Hiroshi
Yamazaki Kentaro
Morita Satoshi
Ebi Masahide
Otsuji Toshio
Ando Masahiko
Seki Nobuhiko
Yamaguchi Kensei
Takahashi Yasuo
Taku Keisei
Sato Mikio
Nakashima Koji
Suyama Koichi
Source :: Annals of Oncology. 25:ii78
Publication Year :: 2014
Publisher :: Elsevier BV, 2014.

Subjects :: Oncology
medicine.medical_specialty
Bevacizumab
Colorectal cancer
business.industry
Hematology
medicine.disease
First line treatment
Internal medicine
medicine
FOLFIRI
business
medicine.drug

Tools